WuXi XDC Cayman (HKSE:02268) Inventories, Raw Materials & Components: HK$191 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:02268 WuXi XDC Cayman Inc HKSE:02268
50 GF Score
Price HK$71.25
! 3 Warning Signs
View Full Analysis

What is WuXi XDC Cayman Inventories, Raw Materials & Components?

WuXi XDC Cayman HKSE:02268 +1.86% 50 Inventories, Raw Materials & Components is HK$191 Mil as of Dec. 2025. GuruFocus rates HKSE:02268 with a GF Score™ of 50/100. The stock has 3 warning signs investors should review.

WuXi XDC Cayman's inventories, raw materials & components for the quarter that ended in Dec. 2025 was HK$191 Mil.

WuXi XDC Cayman's quarterly raw materials increased from Dec. 2024 (HK$127 Mil) to Jun. 2025 (HK$199 Mil) but then declined from Jun. 2025 (HK$199 Mil) to Dec. 2025 (HK$191 Mil).

WuXi XDC Cayman's annual raw materials increased from Dec. 2023 (HK$51 Mil) to Dec. 2024 (HK$127 Mil) and increased from Dec. 2024 (HK$127 Mil) to Dec. 2025 (HK$191 Mil).

WuXi XDC Cayman Inventories, Raw Materials & Components Historical Data

* Premium members only.

The historical data trend for WuXi XDC Cayman's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

WuXi XDC Cayman Inventories, Raw Materials & Components Chart

WuXi XDC Cayman Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Inventories, Raw Materials & Components
Get a 7-Day Free Trial 29.13 70.28 51.19 126.73 191.28

WuXi XDC Cayman Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 143.97 126.73 199.08 191.28 347.84
HKSE:02268
50GF Score
WuXi XDC Cayman Inc HKSE:02268
Inventories, Raw Materials & Components is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

WuXi XDC Cayman Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.

What does a Inventories, Raw Materials & Components of HK$191 Mil mean?
WuXi XDC Cayman (HKSE:02268) has a Inventories, Raw Materials & Components of HK$191 Mil as of Dec. 2025. Raw materials are the components a company uses for its main products. View historical data on WuXi XDC Cayman and its competitors.
Is WuXi XDC Cayman's Inventories, Raw Materials & Components too high?
WuXi XDC Cayman's current Inventories, Raw Materials & Components is HK$191 Mil. Overall, WuXi XDC Cayman has a GF Score™ of 50/100, reflecting its overall financial health beyond just this single metric.
How does WuXi XDC Cayman's Inventories, Raw Materials & Components compare to TMO and DHR?
WuXi XDC Cayman's Inventories, Raw Materials & Components of HK$191 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Raw Materials & Components for a Medical Diagnostics & Research company?
A good Inventories, Raw Materials & Components depends on the Medical Diagnostics & Research industry context. However, Inventories, Raw Materials & Components should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Raw Materials & Components mean?
A high Inventories, Raw Materials & Components can signal that a stock is expensive relative to its fundamentals. Raw materials are the components a company uses for its main products. View historical data on WuXi XDC Cayman and its competitors. WuXi XDC Cayman's current Inventories, Raw Materials & Components is HK$191 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is WuXi XDC Cayman stock overvalued right now?
WuXi XDC Cayman (HKSE:02268) has a current Inventories, Raw Materials & Components of HK$191 Mil. The current Inventories, Raw Materials & Components is HK$191 Mil. WuXi XDC Cayman's overall GF Score™ is 50/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Raw Materials & Components calculated?
Inventories, Raw Materials & Components is calculated from a company's financial statements. For WuXi XDC Cayman (HKSE:02268), the current Inventories, Raw Materials & Components is HK$191 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

WuXi XDC Cayman Business Description

Other Exchanges L74:Germany
Address No. 11 Xinhui Ring Road, Xinwu, Jiangsu Province, Wuxi, CHN
WuXi XDC Cayman Inc is a CRDMO focused on the ADC and broader bioconjugate market and is the only one dedicated to providing integrated and end-to-end services. Leveraging expertise in both biologics and small molecules, it offers interdisciplinary and comprehensive services, covering bioconjugate discovery, research, development, and manufacturing. The company provides these services from proximately located laboratories and manufacturing facilities, resulting in the reduction of development timeline and costs. As a fully integrated one-stop bioconjugate discovery, development, and manufacturing platform, its mission is to continuously enhance its platform and propel and transform the development of the bioconjugate industry.
50GF Score

Get the complete analysis for HKSE:02268

Inventories, Raw Materials & Components is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$71.25
Price